Yuanquan Wu has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Irshat Ibrahim

    Department of Hepatobiliary and Pancreatic Surgery, The First People's Hospital of Kashgar, 120 Yingbin Road, Kashgar Prefecture 844000, China

    4 shared publications
  • Kahaer Tuerxun

    Department of Hepatobiliary and Pancreatic Surgery, The First People's Hospital of Kashgar, 120 Yingbin Road, Kashgar Prefecture 844000, China; Xinjiang Key Laboratory of Artificial Intelligence assisted Imaging Diagnosis, Kashi (Kashgar) 84400, China

    4 shared publications
  • Abudoukeyimu Yasheng

    Department of Hepatobiliary and Pancreatic Surgery, The First People's Hospital of Kashgar, 120 Yingbin Road, Kashgar Prefecture 844000, China

    3 shared publications
  • Zainuer Yusupu

    Department of Hepatobiliary and Pancreatic Surgery, The First People's Hospital of Kashgar, 120 Yingbin Road, Kashgar Prefecture 844000, China

    3 shared publications
  • Aabudouxikuer Abudoumijiti

    Department of Hepatobiliary and Pancreatic Surgery, The First People's Hospital of Kashgar, 120 Yingbin Road, Kashgar Prefecture 844000, China

    1 shared publication
  • Abudouxikuer Abudoumijiti

    Department of Hepatobiliary and Pancreatic Surgery, The First People's Hospital of Kashgar, 120 Yingbin Road, Kashgar Prefecture 844000, China

    1 shared publication

Latest Publications

  • Open Access

    Untargeted metabolomics reveals postoperative metabolic dynamics in hepatic cystic echinococcosis patients

    by Kahaer Tuerxun, Abudouxikuer Abudoumijiti, Zainuer Yusupu, Rousitaimujiang Yimamu, Ronghua Tang, Ziru Wang, Abudoukeyimu Yasheng, Irshat Ibrahim, Yuanquan Wu


  • Open Access

    Perioperative outcomes and hospitalization costs of radical vs. conservative surgery for hepatic cystic echinococcosis: A retrospective study

    by Honggang Shi, Kahaer Tuerxun, Aizizaimu Yusupu, Zainuer Yusupu, Qilin Xu, Yibin Jia, Musitaba Maimaitireyimu, Tuerhongaji Maimaitiaili, Muzaipaer Muhetajiang, Jiaxin Lin, et al.

    Background: Surgical intervention is a crucial treatment for hepatic cystic echinococcosis. However, the choice between radical and conservative surgery remains controversial. This study aimed to compare the perioperative outcomes and hospitalization costs between radical and conservative surgery for hepatic cystic echinococcosis. Method: A retrospective cohort study was conducted on patients undergoing surgical treatment at the First People’s Hospital of Kashi Prefecture from July 1, 2012, to October 1, 2023. Propensity score-matching analysis was utilized to mitigate patient selection bias between the two surgical groups. Result: Of the 434 patients included, 324 underwent conservative surgery and 110 underwent radical surgery. After propensity score-matching, 182 conservative surgery and 102 radical surgery patients were compared. Radical surgery patients experienced longer operative time, higher intraoperative blood loss, increased blood transfusion, and higher costs compared to conservative surgery patients. However, no differences were observed in short-term outcomes, including overall morbidity, death, bile leak, effusion, pulmonary infection, incision infection, intestinal obstruction, ICU stay, abdominal drainage time, and postoperative hospital stays. Conclusion: This study suggests that radical surgery is associated with greater surgical complexity and higher hospitalization costs, while it doesn’t offer a significant short-term advantage. Conservative surgery may be a viable option in resource-limited settings or for patients unsuitable for complex procedures. Further research with long-term follow-up is needed to determine the optimal approach.


  • Comparative proteomics analysis of samples from hepatic cystic echinococcosis patients using data-independent acquisition approach

    by Kahaer Tuerxun, Rong-Hua Tang, Aabudouxikuer Abudoumijiti, Zainuer Yusupu, Aizemaiti Aikebaier, Salamu Mijiti, Irshat Ibrahim, Yan-Long Cao, Abudoukeyimu Yasheng, Yuan-Quan Wu


  • Open Access

    Neutrophil Extracellular Traps (NETs) Are Associated with Type 2 Diabetes and Diabetic Foot Ulcer Related Amputation: A Prospective Cohort Study

    by Irshat Ibrahim, Yilimire Nuermaimaiti, Gulijianaiti Maimaituxun, Xinling Luo, Mailudemu Maimaituxun, Azimat Akbar, Kahaer Tuerxun, Yuanquan Wu

    Introduction The prevalence of diabetes mellitus and its sequelae has been on the rise, and diabetic foot ulcer (DFU) is the leading cause of non-traumatic lower limb amputation globally. The rising occurrence and financial burden associated with DFU necessitate improved clinical assessment and treatment. Diabetes has been found to enhance the formation of neutrophil extracellular traps (NETs) by neutrophils, and excessive NETs have been implicated in tissue damage and impaired wound healing. However, there is as yet insufficient evidence to clarify the value of NETs in assessing and predicting outcomes of DFU. Methods We designed this prospective study with three cohorts formed from type 2 diabetes mellitus (T2DM) patients with DFU (n = 200), newly diagnosed T2DM patients (n = 42), and healthy donors (n = 38). Serum levels of NETs were detected for all groups, and the prognostic value for DFU-related amputation was analyzed. Results The results showed that serum NET levels of the DFU group were significantly higher than in the T2DM group (P < 0.05), which also had significantly elevated serum NET levels compared to healthy donors (P < 0.05). Multivariate Cox regression showed that serum NET levels, diabetic foot surgical history, and Wagner grade were the risk factors for amputation (P < 0.05), and these three variables also exhibited the highest coefficient values in additional Lasso Cox regression. For patients with DFU, Kaplan-Meier curves showed that high serum NET levels associated with higher amputation probability (HR = 0.19, P < 0.01) and ROC curve based on NET value showed good validity for amputation (AUC: 0.727, CI 0.651–0.803). Conclusion Elevated serum NET levels serve as an easily accessible serological prognostic marker for assessing the risk of DFU-related amputation, thereby offering evaluation metrics for healthcare providers. Further investigations are necessary to understand the mechanisms driving this relationship.


  • Open Access

    Effectiveness of a Clinical Pathway for Hepatic Cystic Echinococcosis Surgery in Kashi Prefecture, Northwestern China: A Propensity Score Matching Analysis

    by Irshat Ibrahim, Abudoukeyimu Yasheng, Kahaer Tuerxun, Qi-Lin Xu, Maimaitituerxun Tuerdi, Yuan-Quan Wu

    Introduction Surgical treatment for hepatic cystic ehinococcosis (CE) is not standardized in Kashi Prefecture. Previous evidence identified effectiveness of a clinical pathway in the field of liver surgery. However, proof of a clinical pathway program, especially for CE patients, is lacking. This study aimed to assess the validity of a clinical pathway for hepatic CE surgery performed on patients from Kashi Prefecture. Methods A clinical pathway was developed and implemented by a multidisciplinary team for patients undergoing hepatic CE surgery. Two groups were formed from patients undergoing hepatic CE surgery during a defined period before and after implementing a clinical pathway. Additionally, a propensity score matching analysis was performed. Results In the overall analysis (n = 258) as well as the matched analysis (n = 166), after implementing the clinical pathway, hospital stay was significantly reduced from 13 to 10 days and from 14 to 10 days, respectively (P < 0.05). Postoperative morbidity did not increase. Cost analysis showed a significant decrease in median costs of medication and nursing in favor of the clinical pathway (medication: 5400 CNY vs. 6400 CNY, P = 0.038; nursing: 3200 CNY vs. 4100 CNY, P = 0.02). Conclusion Implementing the clinical pathway for hepatic CE surgery is feasible and safe. The clinical pathway achieved significant reduction of hospital stay without compromising postoperative morbidity. Costs of medication and nursing are significantly reduced. The clinical pathway program is valid and propagable to a certain extent, especially in remote, poor-resourced medical centers in endemic areas.